- Net income for Apollo Hospitals in Q4 was 3.9 billion rupees, which is a 54% increase compared to the previous year and higher than the estimated 3.74 billion rupees.
- The company’s overall revenue reached 55.9 billion rupees, marking a 13% year-over-year increase but slightly below the estimate of 56.2 billion rupees.
- Healthcare Services Revenue rose by 10% to 28.4 billion rupees year-over-year.
- Diagnostics and Retail Health Revenue increased by 11% to 3.94 billion rupees, slightly under the estimate of 4.02 billion rupees.
- Digital Health and Pharmacy Distribution saw a 17% growth in revenue, totaling 23.8 billion rupees, surpassing the estimate of 23.28 billion rupees.
- Total costs amounted to 51.4 billion rupees, an 11% increase from the previous year.
- Other income was 611 million rupees, significantly higher than the previous year’s 281 million rupees.
- The EBITDA was reported at 7.7 billion rupees, close to the estimated 7.85 billion rupees.
- Apollo Hospitals declared a dividend of 10 rupees per share.
- The company plans to set up a 500-bed hospital in Bengaluru, investing 9.44 billion rupees, and acquire an existing hospital nearby for 2.85 billion rupees.
- Apollo Hospitals stock is currently rated with 26 buys, 2 holds, and 1 sell by analysts.
“`
A look at Apollo Hospitals Enterprise Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking at the Smartkarma Smart Scores for Apollo Hospitals Enterprise, the overall outlook appears promising. With a solid momentum score of 4, the company seems to be on an upward trajectory. This indicates that Apollo Hospitals Enterprise is likely experiencing positive price trends that reflect its continued growth and potential. Alongside this, the company also scores well in the areas of growth and resilience, with scores of 3 for both factors. This suggests that Apollo Hospitals Enterprise is positioned well for future expansion and has the ability to withstand market challenges.
Although the company’s value and dividend scores are average, with scores of 2 for both factors, the strong performance in momentum, growth, and resilience bodes well for Apollo Hospitals Enterprise‘s long-term outlook. As a leading player in India’s healthcare sector, owning and operating hospitals, pharmacies, clinics, and health plans across various locations, Apollo Hospitals Enterprise is poised for continued success and growth in the coming years.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
